The American Osteopathic College of Allergy and Immunology (AOCAI) and the American Osteopathic College of Pathologists (AOCP) will join forces today for a series of case-based sessions. They will highlight new disorders and treatment modalities in clinical immunology and provide updates in the various aspects of pathology, such as cytopathology and forensic.
This is the second time the two inter-related colleges have collaborated on an educational session for the general audience, said Massoud Mahmoudi, DO, PhD, president and co-chair of the American Osteopathic College of Allergy and Immunology.
The program started Saturday with the session “Global Pathology” and wrapped up with the two-hour session “Information Anywhere: Evidence-Based Mobile Apps and Resources.” It resumes today in Room 201A, Level 100, Convention Center at 9:30 a.m. with the session “Forensic Cases: Investigation to Certification of Death.” The whole program can be found on the OMED App or in the Schedule section of the OMED News.
Dr. Mahmoudi said attendees can benefit from the joint pathology and immunology sessions by learning about both ends of the disease spectrum.
“When combined, pathology and immunology studies the mechanism of disease, how the disease is developed and how the human immune system reacts,” he said.
In the “Treatment Updates in Clinical Immunology,” session at 1:30 p.m. today, Dr. Mahmoudi will review monoclonal antibodies, among other treatments, that have either been approved by the US Food and Drug Administration or are in the pipeline for approval not only for allergies, but other immune disorders.
In addition, the session will outline current guidelines and recent studies that help with understanding immune disorder treatment.
The second series of lectures will focus on the discovery of new disorders in the immune system as well as a new immunodeficiency found in the ACGME Osteopathic Focused Fellowship program. Speakers will discuss various mutations such as intracellular signaling, and their relationships with immunodeficiency disorders.
“Nearly every state has newborn screening for immunodeficiency,” said Robert W. Hostoffer, DO, PhD, one of the speakers of the immunodeficiency lectures. “It is important that the clinician understand the pathophysiology, diagnosis and treatment. What was rare is now common due to technological advancements.”
Dr. Mahmoudi said many of the topics in immunology and pathology not only cross paths with each other, but also with other areas of medicine.
“We really want to familiarize the audience with the existence of all the modalities in different fields,” he said. “We really can collaborate on a variety of areas because there is a lot of overlapping. In immunology, we do the same as ear/nose/throat dealing with sinus problems and with pathology, the overlapping parts are the diagnostic tools.”